Therapeutic Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Althea Med J. 2025;12(3):161-171. doi:10.15850/amj.v12n3.4209